US Underuse of GLP-1RA, SGLT-2i in Type 2 Diabetes Persists

A large, US study found that just 1 in 8 patients with type 2 diabetes received first-line medications for comorbid atherosclerotic cardiovascular disease, heart failure, and diabetic nephropathy.
First Look

source https://www.medscape.com/viewarticle/968488?src=rss

Comments

Popular posts from this blog

A Large Multicenter Prospective Study of Community-Onset Healthcare Associated Bacteremic Urinary Tract Infections in the Era of Multidrug Resistance: Even Worse than Hospital Acquired Infections?

New AAFP practice guideline sets blood pressure targets for adults with hypertension